Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, the Netherlands: a molecular epidemiological study.

Autor: Rümke LW; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, the Netherlands., Davies MA; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Vestjens SMT; Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, the Netherlands.; Department of Medical Microbiology and Immunology, Diakonessenhuis, Utrecht, the Netherlands., van der Putten BCL; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Bril-Keijzers WCM; Netherlands Reference Laboratory for Bacterial Meningitis (NRLBM), Amsterdam UMC location AMC, Amsterdam, the Netherlands., van Houten MA; Spaarne Gasthuis Academy (Former Linneaus Institute), Hoofddorp, the Netherlands., Rots NY; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Wijmenga-Monsuur AJ; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., van der Ende A; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., de Gier B; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Vlaminckx BJM; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, the Netherlands., van Sorge NM; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.; Netherlands Reference Laboratory for Bacterial Meningitis (NRLBM), Amsterdam UMC location AMC, Amsterdam, the Netherlands.

Publikováno v: Journal of clinical microbiology [J Clin Microbiol] 2024 Oct 16; Vol. 62 (10), pp. e0076624. Date of Electronic Publication: 2024 Aug 28.

Informed consent for national registration of COVID-19 vaccination caused information bias of vaccine effectiveness estimates mostly in older adults: a bias correction study.

Autor: van Werkhoven CH; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: c.h.vanwerkhoven@umcutrecht.nl., de Gier B; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., McDonald SA; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., de Melker HE; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Hahné SJM; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., van den Hof S; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Knol MJ; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Publikováno v: Journal of clinical epidemiology [J Clin Epidemiol] 2024 Oct; Vol. 174, pp. 111471. Date of Electronic Publication: 2024 Jul 18.

Disease burden of psittacosis in the Netherlands

Autor: de Gier, B., Hogerwerf, L., Dijkstra, F., van der Hoek, W.

Publikováno v: Epidemiology and Infection, 2018 Feb 01. 146(3), 303-305.

Externí odkaz: https://www.jstor.org/stable/26523223

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.

Autor: Monge S; Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.; CIBER on Infectious Diseases, Madrid, Spain., Humphreys J; Epiconcept, Paris, France., Nicolay N; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden., Braeye T; Sciensano, Elsene, Belgium., Van Evercooren I; Sciensano, Elsene, Belgium., Holm Hansen C; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Sacco C; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy.; European Programme on Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden., Mateo-Urdiales A; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy., Castilla J; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; CIBER on Epidemiology and Public Health, Madrid, Spain., Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; CIBER on Epidemiology and Public Health, Madrid, Spain., de Gier B; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Hahné S; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Meijerink H; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Kristoffersen AB; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Machado A; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal., Soares P; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal., Nardone A; Epiconcept, Paris, France., Bacci S; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden., Kissling E; Epiconcept, Paris, France., Nunes B; Epiconcept, Paris, France.

Publikováno v: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Apr; Vol. 18 (4), pp. e13292.

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.

Autor: Fontán-Vela M; National Centre of Epidemiology, Carlos III National Health Institute (ISCIII), Madrid, Spain.; Public Health and Epidemiology research group, School of Medicine and Health Sciences, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain., Kissling E; Epiconcept, Paris, France., Nicolay N; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Braeye T; Sciensano, Elsene, Belgium., Van Evercooren I; Sciensano, Elsene, Belgium., Holm Hansen C; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark., Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark., Fabiani M; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy., Mateo-Urdiales A; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy., AlKerwi A; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg., Schmitz S; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg., Castilla J; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., Martínez-Baz I; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., de Gier B; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Hahné S; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Meijerink H; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Starrfelt J; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Nunes B; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia, Lisboa, Portugal., Caetano C; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia, Lisboa, Portugal., Derrough T; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Nardone A; Epiconcept, Paris, France., Monge S; National Centre of Epidemiology, Carlos III National Health Institute (ISCIII), Madrid, Spain.; CIBER on Infectious Diseases (CIBERINFEC), Madrid, Spain.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Jan; Vol. 29 (1).